Loading...
Market
What percentage of the $500 million allocated by Gavi will be spent on Mpox vaccines by December 31, 2024?
2
Resolution / Starting Odds
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Gavi's official reports or press releases
Story
Gavi Allocates $500 Million for Mpox Vaccine Response in Africa
Aug 15, 2024, 05:11 PM
Gavi, the global vaccine alliance, has announced it has up to $500 million available to address the escalating mpox outbreak in Africa. The funds are intended to boost vaccine supplies to countries affected by the health emergency. Gavi's chief executive, Sania Nishtar, confirmed the financial commitment, emphasizing the urgency of the response as the outbreak becomes a global concern.
View original story
Similar markets
Yes • 50%
No • 50%
1-5 countries • 25%
6-10 countries • 25%
11-15 countries • 25%
16+ countries • 25%
0-5 million doses • 25%
5.1-10 million doses • 25%
10.1-15 million doses • 25%
15.1+ million doses • 25%
Less than 50% • 25%
50% - 75% • 25%
75% - 90% • 25%
More than 90% • 25%
Less than 1 million • 25%
1 million to 2 million • 25%
2 million to 3 million • 25%
More than 3 million • 25%
WHO • 25%
GAVI • 25%
Bill & Melinda Gates Foundation • 25%
Other • 25%
Less than 500,000 • 25%
500,000 to 1 million • 25%
1 million to 2 million • 25%
More than 2 million • 25%
Less than 50,000 • 25%
50,000 to 100,000 • 25%
100,001 to 200,000 • 25%
More than 200,000 • 25%
Yes • 50%
No • 50%
Less than 200,000 • 25%
200,000 to 300,000 • 25%
300,001 to 400,000 • 25%
More than 400,000 • 25%
